Lupin

Lupin, headquartered in India and operating in the Pharmaceutical Preparation Manufacturing industry, reported its Scope 1 emissions as approximately 61,951,000 kg CO2e in 2026. Its Scope 2 market-based emissions for the same year were about 187,863,000 kg CO2e. Scope 3 emissions in 2026 totalled approximately 1,065,547,000 kg CO2e, with significant contributions from purchased goods and services (approximately 477,762,000 kg CO2e) and use of sold products (about 393,486,000 kg CO2e).

Lupin is committed to ambitious climate action, having signed The Climate Pledge in November 2024. The company has set Science Based Targets initiative (SBTi) validated near-term targets. Lupin Ltd commits to an absolute reduction of Scope 1 and Scope 2 GHG emissions by 42.0% by FY2030 from a FY2023 base year. Additionally, the company aims to reduce Scope 3 GHG emissions from specific categories, including purchased goods and services, fuel- and energy-related activities, and transportation, by 61.07% per INR value added by FY2033 from a FY2024 base year. These targets are considered consistent with reductions required to keep global warming to 1.5°C. The company also has an internal target to reduce its Scope 1 and Scope 2 GHG emissions by 15% by 2030, using a 2021 base year.